323 related articles for article (PubMed ID: 31166768)
1. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
[TBL] [Abstract][Full Text] [Related]
3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
4. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
[No Abstract] [Full Text] [Related]
6. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
[TBL] [Abstract][Full Text] [Related]
7. Advanced imaging of cardiac sarcoidosis.
Schatka I; Bengel FM
J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
[TBL] [Abstract][Full Text] [Related]
8. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
[TBL] [Abstract][Full Text] [Related]
9. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
10. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
Brancato SC; Arrighi JA
J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
[No Abstract] [Full Text] [Related]
11. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
[TBL] [Abstract][Full Text] [Related]
12. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.
Mc Ardle BA; Leung E; Ohira H; Cocker MS; deKemp RA; DaSilva J; Birnie D; Beanlands RS; Nery PB
J Nucl Cardiol; 2013 Apr; 20(2):297-306. PubMed ID: 23288545
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
Györik S; Ceriani L; Menafoglio A; Gallino A; Wyttenbach R
Thorax; 2007 Jun; 62(6):560. PubMed ID: 17536038
[No Abstract] [Full Text] [Related]
15. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
[TBL] [Abstract][Full Text] [Related]
17. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis.
Sharp MB; Soufer A; Abdelmessih M; Rosenfeld LE; Baldassarre LA; Miller EJ
J Nucl Cardiol; 2020 Apr; 27(2):688-690. PubMed ID: 30737635
[No Abstract] [Full Text] [Related]
18. Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.
Maeda D; Kanzaki Y; Fujita S; Inuyama M; Takashima S; Miyamura M; Terasaki F; Hoshiga M
ESC Heart Fail; 2019 Aug; 6(4):889-893. PubMed ID: 31264810
[TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
Ohira H; Tsujino I; Yoshinaga K
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1773-83. PubMed ID: 21559980
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Higuchi Y; Kimoto Y; Tanoue R; Tokunou T; Tomonari K; Maeda T; Horiuchi T
Intern Med; 2018 Jun; 57(11):1601-1604. PubMed ID: 29321427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]